Posted by Michael Wonder on 22 Jun 2022
MSAC publishes agenda for October 2022 ESC meeting
22 June 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on 6 - 7 October 2022.
The agenda currently has 12 items. Applications of note include:
- 1675 – Whole genome sequencing for the diagnosis of mitochondrial disease
- 1684 – Genetic testing for variants associated with haematological malignancies
- 1691 – PromarkerD testing in patients with type 2 diabetes mellitus to determine the risk of developing diabetic kidney disease
- 1707 – Measuring minimal residual disease in acute lymphoblastic leukaemia using next generation sequencing assays to guide treatment decision
- 1721 – Small gene panel testing for non-small cell lung cancer
- 1723 – Brexucabtagene autoleucel for relapsed or refractory adult B-precursor acute lymphoblastic lymphoma
Read ESC agenda
Posted by:
Michael Wonder